BABAN

This brand name is authorized in Nigeria.

Active ingredients

The drug BABAN contains one active pharmaceutical ingredient (API):

1
UNII QTG126297Q - DICLOFENAC SODIUM
 

Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.

 
Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-7559 Tablet BABAN TABLETS TAB 50 mg 1 X 10 29 CMS-PP-401264 BABAN TABLETS DICLOFENAC SODIUM 50MG EACH UNCOATED TABLETS CONTAINS DICLOFENAC SODIUM BP 50MG EXCIPIENTS Microcrystalline cellulose (MCCP) Starch Cros Carmellose sodium (CCS) Talcum Starch for paste purified water Magnesium Stearate Polyethylene Glycol (PEG) 6000 Aerosil Titanium Dioxide Ethyl Cellulose Hydroxypropyl Methylcellulose (HPMC) Erythrosine Isopropyl Alcohol (IPA) Methylene Dichloride (MDC) B4-7559 Drugs Imported Products 110 Prescription Only Medicine (POM) 1/29/2024 PATRICKLINGO PHARMACEUTICALS LIMITED, 107, Upper Iweka Road, Onitsha, Anambra State, Nigeria. 8033443825 patricklingopharma@gmail.com FANTASY DRUGS PVT. LTD, PLOT NO. C-66 TO 69, D-33 TO 36, INDUSTRIAL AREA, HAJIPUR, VAISHALI, BIHAR-844101, INDIA, India 28/02/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M01AB05 Diclofenac M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-7559

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.